@conference{646885541d5247158301a5adeebd2121,
title = "Anaplastic oligodendroglial tumors: The Cleveland Clinic experience.",
author = "Neda Hashemi-Sadraei and Irizarry, {Lizbeth Robles} and Mital Patel and Tekautz, {Tanya M.} and Murphy, {Erin Sennett} and Violette Recinos and Chao, {Samuel T.} and Suh, {John H.} and Peereboom, {David M.} and Glen Stevens and Weil, {Robert J.} and Vogelbaum, {Michael A.} and Barnett, {Gene H.} and Ahluwalia, {Manmeet Singh}",
note = "2100 Background: Anaplastic oligodendroglial tumors include both anaplastic oligodendroglioma (AO), and anaplastic oligoastrocytoma (AOA), histological categories of WHO grade 3 gliomas. There is limited data on specific prognostic factors for patients with these tumors. Methods: After obtaining IRB approval, the Cleveland Clinic Brain Tumor and Neuro-Oncology Center's database was used to identify patients with histologically confirmed AO and AOA at the time of diagnosis.; Journal of Clinical Oncology ; Conference date: 01-01-2020",
year = "2012",
month = may,
day = "20",
doi = "10.1200/JCO.2012.30.15_SUPPL.2100",
language = "American English",
}